Relmada Therapeutics, Inc. (RLMD)
6.38
+0.11
(+1.75%)
USD |
NASDAQ |
Jun 10, 16:00
6.385
0.00 (0.00%)
Pre-Market: 20:00
Relmada Therapeutics EBITDA (TTM)
EBITDA (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EBITDA (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -- |
| December 31, 2025 | -- |
| September 30, 2025 | -- |
| June 30, 2025 | -- |
| March 31, 2025 | -- |
| December 31, 2024 | -- |
| September 30, 2024 | -- |
| June 30, 2024 | -- |
| March 31, 2024 | -- |
| December 31, 2023 | -- |
| September 30, 2023 | -- |
| June 30, 2023 | -- |
| March 31, 2023 | -- |
| December 31, 2022 | -- |
| September 30, 2022 | -- |
| June 30, 2022 | -- |
| March 31, 2022 | -- |
| December 31, 2021 | -- |
| September 30, 2021 | -- |
| June 30, 2021 | -- |
| March 31, 2021 | -- |
| December 31, 2020 | -- |
| September 30, 2020 | -- |
| June 30, 2020 | -- |
| March 31, 2020 | -- |
| Date | Value |
|---|---|
| June 30, 2019 | -- |
| March 31, 2019 | -- |
| December 31, 2018 | -- |
| September 30, 2018 | -- |
| June 30, 2018 | -- |
| March 31, 2018 | -- |
| December 31, 2017 | -- |
| September 30, 2017 | -- |
| June 30, 2017 | -- |
| March 31, 2017 | -- |
| December 31, 2016 | -- |
| September 30, 2016 | -- |
| June 30, 2016 | -- |
| March 31, 2016 | -- |
| December 31, 2015 | -- |
| September 30, 2015 | -- |
| June 30, 2015 | -- |
| March 31, 2015 | -- |
| December 31, 2014 | -- |
| September 30, 2014 | -- |
| February 28, 2014 | -- |
| September 30, 2013 | -- |
| August 31, 2013 | -- |
| May 31, 2013 | -- |
| February 28, 2013 | -- |
EBITDA Definition
EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.
EBITDA (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median